🇺🇸 FDA
Patent

US 6403635

Method of treating atherosclerosis or restenosis using microtubule stabilizing agent

expired A61KA61K31/335A61K31/337

Quick answer

US patent 6403635 (Method of treating atherosclerosis or restenosis using microtubule stabilizing agent) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jun 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jun 11 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/335, A61K31/337, A61K9/0024, A61P